Adaptive Phage Therapeutics, Inc. — Form D/A
Adaptive Phage Therapeutics, Inc. of GAITHERSBURG, MD, a company, filed a Form D amendment with the SEC on 2020-08-27. The offering totals $3.6M. Industry: Pharmaceuticals.
Offering
- Filed: 2020-08-27
- Form: D/A
- Accession: 0001701259-20-000003
- Industry: Pharmaceuticals
- Exemptions: 06c
- Total offering: $3.6M
- Remaining: $3.6M
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-373895
Issuer
- Name: Adaptive Phage Therapeutics, Inc.
- CIK: 0001701259
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 708 Quince Orchard Road, GAITHERSBURG, MD, 20878
- Phone: 8449720500
Officers, directors & promoters (23)
| Name | Role | Location |
|---|
| Raymond Louis Martz | Director | Gaithersburg, MD |
| Carl Louis Merril | Director | Gaithersburg, MD |
| Gregory Louis Merril | Director | Gaithersburg, MD |
| Subhendu Louis Basu | Executive Officer | Gaithersburg, MD |
| Carl Louis Merril | Executive Officer | Gaithersburg, MD |
| Gregory Louis Merril | Executive Officer | Gaithersburg, MD |
| Gregory Merril | Director | Ness Ziona, L3 |
| Gregory Merril | Executive Officer | Ness Ziona, L3 |
| Jonathan L Leff | Director | Gaithersburg, MD |
| Jana L Jensen | Director | Gaithersburg, MD |
| Carl R Merril | Director | Gaithersburg, MD |
| Carl R Merril | Executive Officer | Gaithersburg, MD |
| Ian L Hardy | Director | Gaithersburg, MD |
| Michael L Orndorff | Executive Officer | Gaithersburg, MD |
| Gregory L Merril | Director | Gaithersburg, MD |
| Gregory L Merril | Executive Officer | Gaithersburg, MD |
| Gregory L Merril | Promoter | Gaithersburg, MD |
| Jesse L Goodman | Director | Gaithersburg, MD |
| Raymond L Martz | Director | Gaithersburg, MD |
| Martin L Heidecker | Director | Gaithersburg, MD |
| Evan L Loh | Director | Gaithersburg, MD |
| Subhendu L Basu | Executive Officer | Gaithersburg, MD |
| William Louis Mutryn | Director | Gaithersburg, MD |
Other filings by this issuer (7)
More